The challenges in performing and accessing clinical G6PD testing are emphasized by the fact that despite the large number of moderate- and high-complexity clinical laboratories in the United States, only 47 participated in the G6PDS-A 2020 College of American Pathologists (CAP) proficiency survey for testing for G6PD deficiency. This evidence concerns the gene G6PD and G6PD deficiency.